We are live on ! Find out more
HSCS icon

Heart Test Laboratories

3 hedge funds and large institutions have $5.4K invested in Heart Test Laboratories in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

1.29% less ownership

Funds ownership: 1.43%0.14% (-1.3%)

50% less funds holding

Funds holding: 63 (-3)

91% less capital invested

Capital invested by funds: $61.9K → $5.4K (-$56.5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$4.99K +$2.14K +624 +92%
TRCT
2
Tower Research Capital (TRC)
New York
$382 -$6.1K -1,777 -95%
Bank of America
3
Bank of America
North Carolina
$31 +$3 +1 +14%
HF
4
HRT Financial
New York
-$48K -10,166 Closed
OLVIG
5
Oliver Lagore Vanvalin Investment Group
Michigan
-$1.48K -305 Closed
JP Morgan Chase
6
JP Morgan Chase
New York
-$5 -1 Closed

HSCS Hedge Fund Activity: Q4 2024 in Review

3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2024, worth a combined $5.4K — down 91% from $61.9K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of HSCS and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $2.14K. The largest seller was HRT Financial, exiting entirely with an estimated $48K sold.

  • 3 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2024, down from 6 in Q3 2024.
  • Funds reported $5.4K of Heart Test Laboratories stock for Q4 2024, down 91% quarter-over-quarter.
  • 0 funds opened new Heart Test Laboratories positions in Q4 2024 and 3 closed out, a net change of -3 holders.
  • The largest Heart Test Laboratories buyer in Q4 2024 was UBS Group, an estimated $2.14K added.
  • The largest Heart Test Laboratories seller in Q4 2024 was HRT Financial, an estimated $48K sold.

Based on aggregated 13F filings for Q4 2024.